Lunaphore secures $23.6M in funding round

2019 04 24 22 00 7830 Pathology Slide Liver 400

Swiss life sciences firm Lunaphore Technologies has secured 23 million Swiss francs ($23.6 million U.S.) in a funding round led by Japanese investor PHC Holdings.

The round closed on January 15, and the company said it also included investors Redalpine Venture Partners, Occident, and Alpana Ventures.

Lunaphore develops tissue autostainers using microfluidic technology it calls Fast Fluidic Exchange (FFeX). The company plans to use the funding for market and product expansion, particularly for entering the U.S. market and increasing its presence in Europe.

Page 1 of 39
Next Page